A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...
Mental health professionals reveal the hidden signs of anxiety disorders affecting millions of Americans, from mysterious ...
You're probably familiar with the symptoms of anxiety: feeling worried, racing thoughts, and being irritable. But while being ...
14d
News Medical on MSNAnxiety reduction with antidepressants confirmed, long-term effects uncertainA new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.
“Hyperthyroidism is often linked to Graves’ disease, another autoimmune condition that overstimulates the thyroid. Thyroid ...
Most people worry, but for those with generalized anxiety disorder, worries are chronic and lead to symptoms like exhaustion, nausea, and trouble sleeping. The first step toward treatment is ...
21h
Verywell Health on MSNThe Best Time to Take Lexapro for Anxiety, Written by a PharmacistLexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.
My silence regarding my mental health has stemmed from several fears — none of them rational. I was afraid that my mental ...
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage. The ...
H.C. Wainwright analyst Pat Trucchio adjusted the price target for Cybin Inc. (NYSE:CYBN) stock, lowering it to $150.00 from the previous $190.00 while maintaining a Buy rating on the company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results